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Latent membrane protein 1 (LMP1), the Epstein-Barr virus oncoprotein, activates NF-B, phosphatidyl-
inositol 3-kinase, mitogen-activated protein kinase, and c-Jun N-terminal kinase signaling. To determine
global transcriptional changes induced by LMP1 in epithelial cells, genomic analysis of C33A cells stably
expressing LMP1 was performed. Relatively few genes were induced by LMP1. Expression of two members of
the Id (inhibitor of differentiation) family of proteins, Id1 and Id3, was induced in the presence of LMP1 and
confirmed by mRNA and protein in C33A and Rat-1 cells. In Rat-1 foci transformed by LMP1, Id1 protein was
also increased. Id proteins are known negative regulators of E-box proteins that positively regulate p16 and
potentially other cyclin-dependent kinase inhibitors (cdki’s). In LMP1-expressing Rat-1 cells, cdki p27 was
specifically downregulated. Decreased p27 was correlated with increased levels of Cdk2 and increased levels of
phosphorylated retinoblastoma protein. This study describes new properties of LMP1 that likely contribute to
transformation and oncogenesis.
Epstein-Barr virus (EBV) is a ubiquitous human pathogen
that is associated with several malignancies (16, 28). Latent
membrane protein 1 (LMP1) is considered the EBV oncopro-
tein and is expressed in many of the cancers associated with
EBV. LMP1 transforms rodent fibroblasts by conferring an-
chorage-independent growth and loss of contact inhibition
(32). Fibroblasts expressing LMP1 form tumors in nude mice
and can grow under reduced-serum conditions. LMP1 is also
essential for EBV-mediated transformation of B lymphocytes
(13).
LMP1 is an integral membrane protein with a short amino-
terminal cytoplasmic tail, six membrane-spanning domains,
and a cytoplasmic carboxy-terminal domain. LMP1 functions
as a constitutively active tumor necrosis factor (TNF) receptor,
as oligomerization of LMP1 molecules via interactions of the
transmembrane domains brings the carboxyl-terminal domains
in close proximity to induce ligand-independent signaling (6, 8,
9). The carboxyl-terminal domain contains two signaling do-
mains, C-terminal activation regions (CTARs). CTAR1 binds
TNF receptor-associated factors (TRAFs), and CTAR2 binds
the TNF receptor-associated death domain protein (desig-
nated TRADD) that recruits other signaling molecules. Sig-
naling from the C-terminal domain activates NF-B and leads
to activation of several important signaling pathways, including
the mitogen-activated protein kinase (MAPK), c-Jun N-termi-
nal kinase, and phosphatidylinositol 3-kinase (PI3K) pathways
(6).
LMP1 alters the cellular environment by inducing the ex-
pression of a number of genes. Genomic analyses of EBV-
infected and LMP1-expressing lymphocytes indicate that most
of the genes that are induced during EBV infection are a result
of LMP1 and NF-B signaling (3, 4). LMP1 induces the ex-
pression of cell surface receptors, epidermal growth factor
receptor (EGFR) (22), CD40, CD54, and CD95. LMP1 also
induces antiapoptotic proteins such as A20 (8), Bcl-2, cIAP,
and Bfl-1, as well as invasion and angiogenic factors such as
vascular endothelial growth factor, cyclooxygenase-2, and ma-
trix metalloproteinase 9 (24, 34).
To gain greater understanding into the mechanism of trans-
formation of epithelial cells by LMP1, genomic analysis of
C33A cells expressing LMP1 was performed. Two members of
the inhibitor of DNA binding or inhibitor of differentiation
(Id) family of proteins, Id1 and Id3, were upregulated by
LMP1. Induction of Id1 and Id3 mRNA was confirmed by
quantitative PCR and correlated with increased proteins levels.
Increased Id1 protein was detected by immunofluorescence in
Rat-1 foci induced by transformation with LMP1, and Id1 and
Id3 protein levels were increased in Rat-1 LMP1 stable cell
lines. The Id proteins are potent regulators of cellular differ-
entiation and cell cycle progression, and in the Rat-1 stable cell
lines cyclin-dependent kinase inhibitor (cdki) p27 protein lev-
els were reduced, while levels of cyclin-dependent kinase 2
(Cdk2) and phosphorylated retinoblastoma (Rb) protein were
increased. The LMP1 mediated effects upon Id proteins, and
cell cycle proteins were mapped to CTAR1. The data pre-
sented in this study identify key properties of LMP1 that affect
cell cycle progression and likely contribute to transformation
and oncogenesis.
MATERIALS AND METHODS
Plasmids. The initial cloning of wild-type LMP1 and construction of LMP1
deletion mutants, 1–231 (previously, 231-STOP) and 187–351 has been de-
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scribed previously (23). Full-length LMP1 and LMP1 deletion mutants were
subcloned by PCR with Platinum Pfx DNA polymerase (Invitrogen) according to
the manufacturer’s directions. Cloning into the myc-tagged expression vector was
accomplished by amplification with LMP1myc5 (CGACGGATCCATATGGA
ACACGACCTTGAGAGG) and LMP1-3 (ATCACGAGGAATTCAATGTG
GCTTTTCAGCCTAGAC), restriction enzyme digestion, and insertion into the
BamHI and EcoRI sites of M3-pcDNA3 (18). Wild-type LMP1, 1-231, and
187-351 cloned into the expression vector resulted in plasmids pM3-LMP1,
pM3-1-231, pM3-187-351, respectively, expressing three N-terminal myc
epitope tags on LMP1 molecules. Hemagglutinin (HA)-tagged LMP1 was cloned
by amplification with LMP1-HA5 containing the coding sequence of the HA
epitope (GCCGGATCCATGGCTTACCCATACGATGTTCCAGATTACGC
TAGCTTGGGTGGTCATATGGAACACGACCTTGAGAGG) and LMP1-3,
restriction enzyme digestion, and insertion into the BamHI and EcoRI sites of
pBABE. Cloning into pBABE resulted in recombinant retrovirus vectors ex-
pressing N-terminal HA-tagged LMP1, 1-231, and 187-351 in pBABE-HA-
LMP1, pBABE-HA-1-231, and pBABE-HA-187-351, respectively.
Id1 promoter reporter constructs, kindly provided by Takenobu Katagiri, in
pGL3-Basic (Promega) were described previously (12). Full-length reporter plas-
mid ID1-2.1 and truncated reporters ID1-985 and ID1-0.8 contain upstream
promoter regions from 2,100, 985, and 800 bp, respectively. ID1-mutA and
ID1-mutB are derived from ID1-985, which contains the BMP-2 serum-respon-
sive region, and each contains the triple-point mutation (TTT) that alters puta-
tive Egr-1 and Sp1 binding sites, respectively.
Transfection and retrovirus transduction. Cells were transfected with Fu-
GENE 6 (Boehringer Mannheim) according to the manufacturer’s directions.
Recombinant retroviruses were generated as previously described (30) by trans-
fection of 293T cells with pBABE, pBABE-HA-LMP1, pBABE-HA-1-231, or
pBABE-HA-187–351, and VSV-G (pG1-VSV-G)- and gag-pol (pGPZ9)-ex-
pressing plasmids. After 24 h, the transfection medium was removed and re-
placed with fresh medium, and cells were incubated at 33°C overnight. The
following day, culture supernatants were harvested and centrifuged 1,000  g for
10 min to remove any cells or cellular debris. Rat-1 cells were transduced with
clarified 293T culture supernatants overnight with 8 g of Polybrene/ml.
Cell culture and stable cell lines. Cell lines were maintained in Dulbecco
modified Eagle medium (Gibco) supplemented with an antibiotic-antimycotic
mixture and 10% (vol/vol) heat-inactivated fetal bovine serum. Stable cell lines
were established in the human cervical carcinoma cell line C33A by transfection
with vector control pcDNA3 (Invitrogen) or the LMP1-expressing plasmids M3-
LMP1, M3-1-231, and M3-187–351, followed by selection with G418 (0.6 mg/
ml; Gibco). Rat-1 rodent fibroblast stable cell lines were established by trans-
duction with vector control pBABE or LMP1-expressing retroviruses and
selection with puromycin (1 g/ml; Sigma). For serum starvation, selected cells
were grown to confluence and then changed to medium with 0 to 0.2% serum for
24 to 48 h after being washed once with phosphate-buffered saline (PBS) to
remove serum.
RNA isolation and microarray probe synthesis. C33A cells were grown in
100-mm tissue culture plates, and total RNA was isolated with RNeasy Midi
purification kits (QIAGEN) according to the manufacturer’s directions. Eluted
RNA was precipitated with sodium acetate and ethanol and stored at 80°C.
Precipitated RNA was centrifuged, washed with 70% ethanol, and dried. Pel-
leted RNA was dissolved in water, quantitated, and electrophoresed on agarose
gels to assess sample integrity. One quarter of the RNA was aliquoted and mixed
with Direct Protect RPA lysis buffer (Ambion) and frozen at 20°C for future
analysis. Remaining RNA, about 60 g, was mixed with 4.5 g of anchored
oligo(dT) primer [(T)20VN] in a final volume of 40 l, denatured for 10 min at
70°C, and cooled immediately in ice water. cDNA was synthesized with Super-
Script II (Invitrogen) according to the manufacturer’s directions by the addition
of 18 l of 5 buffer, 9 l of deoxynucleoside triphosphates (final concentration,
0.5 mM dCTP, 0.5 mM dATP, 0.5 mM dGTP, and 0.15 mM dTTP), 9 l of
5-(3-aminoallyl)-dUTP (final concentration, 0.3 mM; Molecular Probes), 9 l of
dithiothreitol (0.1 M stock), and 5.1 l of SuperScript II (200 U/l) for 1 h at
42°C. Reaction mixtures were spiked with an additional 3 l of enzyme and
incubated for an additional hour. The reverse transcription reaction was stopped
and RNA was hydrolyzed by the addition of 39 l of 1 M NaOH–2 mM EDTA
and incubation at 65°C for 15 min, followed by neutralization with 39 l of 1 M
HCl. cDNA was concentrated and desalted in Microcon YM-30 (Amicon) ac-
cording to the manufacturer’s directions by the addition of 400 l of nuclease-
free water and centrifugation carried out three times. Probes were labeled with
amine-reactive fluorescent dye with the ARES Alexa Fluor DNA Labeling Kit
(Molecular Probes) according to the manufacturer’s directions. Vector control
pcDNA3 RNA was labeled with 647-nm dye for the Cy5 channel, while LMP1
stable cell line RNA was labeled with 555-nm dye for the Cy3 channel. Dye-
labeled probes were purified with the QIAquick PCR purification kit (QIAGEN)
according to the manufacturer’s directions. cDNA yield and dye labeling effi-
ciency were determined by spectrophotometric measurements according to the
ARES kit directions. Between 2 to 4 g of high-specific-activity probe with a
dye-to-base ratio of 1:18 to 1:25 per reaction mixture was typical.
Probe preparation and array hybridization. Equal amounts of control and
experimental probes, 1 to 1.5 g each, were combined with 35 g of human
COT-1 DNA (Invitrogen) and were concentrated to 25 l with Micro-
conYM-30 (Amicon) columns according to the manufacturer’s directions. To the
probe–COT-1 mixture was added 10 g of yeast tRNA (Invitrogen), 20 g of
poly(A) DNA (Amersham Pharmacia Biotech), 5.3 l of 20 SSC (1 SSC is
0.15 M NaCl plus 0.015 M sodium citrate), 0.7 l of 10% sodium dodecyl sulfate
(SDS), and water to a final volume of 35 l. Samples were placed in a boiling-
water bath for 2 min and then incubated for 15 min at 42°C.
Human microarray slides were obtained from the UNC Lineberger Genomics
Core Facility containing the Compugen oligo series representing more than
18,000 unique genes. Arrays were cross-linked with 600 mJ of UV irradiation,
followed by incubation in prehybridization buffer (3 SSC, 0.1% SDS, and 0.2%
bovine serum albumin) at 65°C for 45 min. Slides were then washed five times
with nuclease-free water, washed one time with 95% ethanol, and dried. Probe
mixtures, adjusted to 35 l, were applied to slides, covered with a coverslip, and
hybridized overnight in hybridization chambers at 65°C. Hybridized arrays were
washed once with room temperature 2 SSC–0.1% SDS to remove the coverslip,
once with room temperature 1 SSC for 5 min, and twice with 0.2 SSC at 65°C
for 5 min. Slides were dried by centrifugation and scanned with an Axon 4000
scanner at 532 and 635 nm. Images were then processed with GenePix software
(Axon) to generate the raw data files that were uploaded to the University of
North Carolina Microarray Database for normalization. Clustering analysis was
performed within the database, and data sets were combined in Microsoft Excel
for manual sorting.
Real-time PCR. Aliquots of RNA used for microarrays were treated with
RNase-Free DNase (QIAGEN) and purified with the RNeasy Mini kit (QIA-
GEN) according to the manufacturer’s directions. RNA concentration and purity
were assessed by spectrophotometric measurements. Primer pairs (Table 1) were
designed using Primer Express (Applied Biosystems). Quantitative reverse tran-
scription-PCR was performed on DNase-treated RNA using the Quantitect
SYBR Green RT-PCR Kit (QIAGEN) according to the manufacturer’s direc-
tions. Amplification of target sequences was detected with an ABI 7900HT
sequence detection system (Applied Biosystems) and analyzed with SDS 2.0
software (Applied Biosystems). The cycle threshold (Ct) was determined as the
number of PCR cycles required for a given reaction to reach an arbitrary fluo-
rescence value within the linear amplification range. The change in Ct (Ct) was
determined between the same gene primer sets and different samples and the
change in Ct (Ct) was determined by adjusting for the difference in the
number of cycles required for actin to reach the Ct. Since each PCRcycle results
in a twofold amplification of each product, the difference was determined as
2Ct.
Cell harvesting and Western blotting. Cell lines were grown in 100-mm tissue
culture plates to 70 to 95% confluency and harvested. Cells were washed with
ice-cold PBS (Gibco) and lysed with 100 to 250 l of RIPA buffer (10 mM
Tris-HCl [pH 8.0], 140 mM NaCl, 1% Triton X-100, 0.1% SDS, 1% deoxycholic
acid, and protease and phosphatase inhibitors ). Cell lysates were clarified by
centrifugation and quantitated by the Bio-Rad DC protein assay system. Samples
were then boiled in SDS sample buffer, and indicated amounts of proteins were
separated by SDS-polyacrylamide gel electrophoresis with 10 or 15% acrylamide
and transferred to Immobilon P membranes (Millipore) for Western blotting
analysis. Primary antibodies used included 	-actin (I-19), HA-probe (Y-11), Id1
(C-20 and Z-8) and Id3 (H-70) (Santa Cruz), p27 (Calbiochem), Cdk2 (BD
Biosciences), Phospho-Rb (Ab-1) (Oncogene), and CS1-4 (anti-LMP1) (Dako).
Bound proteins were detected with horseradish peroxidase-conjugated second-
ary antibodies (Amersham Pharmacia and Dako) and the Supersignal West Pico
system (Pierce), followed by exposure to film.
Rat-1 foci and immunofluorescence. Rat-1 cells were plated at a 1:5 ratio in 6-
or 12-well plates and infected the following day with pBABE or pBABE-HA-
LMP1 retroviruses with 8 g of Polybrene/ml. The medium was changed the
following day and every 2 to 3 days thereafter, and foci were allowed to form for
10 to 15 days. Wells were washed once with PBS and fixed with methanol for 5
min at room temperature. Cells were blocked for 20 min with PBS containing
20% normal goat serum (NGS) and then incubated with primary antibodies in
PBS containing 20% NGS overnight at 4°C. Cells were washed three times with
PBS, incubated with fluorescein isothiocyanate-conjugated secondary antibody
(Jackson Laboratories) in PBS with 20% NGS for 1 h at room temperature, and
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then washed three times with PBS. Stained wells were examined by phase-
contrast and fluorescence microscopy for foci and immunofluorescence.
Id1 promoter luciferase assays. Cells were plated at a 1:5 ratio into six-well
plates 1 day prior to transfection. Cells were transfected with 0.75 g of pRL-
SV40 (Promega), 0.75 g of pGL3-Basic or Id1 promoter plasmids, and 0.75 g
of pcDNA3 or pM3-LMP1. The following day, the medium was changed, and
40 h posttransfection cells were harvested and luciferase activity was assayed with
the Dual-Luciferase reporter assay system (Promega) according to the manufac-
turer’s directions. Relative luciferase activity was determined by dividing the
firefly luciferase activity of the Id1 promoter constructs by the internal control
Renilla luciferase activity. Each condition was done in triplicate and replicated in
different experiments.
RESULTS
Genomic analysis of C33A cells expressing LMP1. LMP1
induces NF-B transcriptional activity, PI3K activity, and
MAPK activity. To determine global transcriptional regulation
by LMP1 in epithelial cells, microarray analysis was performed.
C33A cells were stably transfected with pcDNA3 or M3-LMP1,
and RNA was isolated. Microarray probes were synthesized,
and two-color microarray analysis was performed on chips with
18,000 human genes. Comparisons between the vector control
and LMP1-expressing C33A cells were performed in triplicate.
Raw data files were normalized in the University of North
Carolina Microarray Database, and clustering analysis was per-
formed. Clustering analysis of the triplicate LMP1 arrays did
not reveal linkage between different groups of genes (data not
shown).
To determine individual genes consistently up- or downregu-
lated by LMP1, normalized data files were loaded into Mi-
crosoft Excel and sorted manually by log2 ratio of the means
and medians. Using the criteria of log2 ratio of the means or
medians 
2 or less than 2, which corresponds to a 
4-fold
change in expression, few genes were induced by LMP1 and
none were repressed. Genes induced by LMP1 are listed in
Table 2. Annexin A2 was the most highly induced gene at
nearly sevenfold. Next at 
5-fold were two separate spots
corresponding to Id3. Interestingly, also scoring just above and
below the fourfold cutoff were spots corresponding to Id4 and
Id1, respectively. Vimentin was also upregulated, as has been
previously reported (20). Several other proteins of interest that
were induced slightly less than fourfold were also noted.
Quantitative PCR in C33A Cells. Genes observed to be
increased by LMP1 in the microarrays (Table 2) were tested by
real-time reverse transcription-PCR. Genes whose expression
level was altered less than twofold (Ct  1) were judged to
be unchanged. Genes whose expression was changed more
than twofold (Ct  1) were judged to be regulated by
LMP1, and analysis was repeated three or more times. EGFR,
although not induced on the arrays, is known to be upregulated
by LMP1 in C33A cells (22) and was used as a positive control.
EGFR was induced by LMP1 by quantitative PCR (Fig. 1).
Id1, Id3, vimentin, and annexin A2 upregulation was also con-
firmed by quantitative PCR. The remaining genes that scored
as significant by microarray analysis were unchanged by quan-
titative PCR analysis. These discrepancies in RNA increases
between quantitative PCR and microarray analyses reflect
likely differences in the relative abundance of the mRNAs.
Id1 promoter reporter assays. As LMP1 clearly alters epi-
thelial cell growth, the induction of proteins of the Id family of
proteins was of particular interest. Id proteins bind to helix-
loop-helix transcription factor family members, inhibit differ-
entiation, and promote proliferation. To characterize induc-
tion of the Id1 promoter by LMP1, reporter assays were
performed with Id1 promoter plasmids. Full-length Id1 pro-
moter reporter plasmid contains 2.1 kb of upstream sequences
(ID1-2.1), and promoters truncated to 985 and 800 (ID1-
985 and ID1-0.8) differ by the presence or absence, respec-
tively, of serum-responsive elements between 985 and 947
bases. Mutants ID-mutA and ID1-mutB are derived from ID1-
985 but contain triple-point mutations that alter putative Egr-1
and Sp1 binding sites, respectively, that have previously been
shown to be responsible for activation of the promoter by
serum components. Promoter reporter constructs were assayed
with vector control or LMP1 under various conditions and cell
lines, including C33A or Rat-1 cells, transient or stable cell
lines, and presence or absence of serum. Activation of Id1
promoter reporter plasmids by LMP1 was not detected under
any conditions. As represented in Fig. 2 by C33A cells tran-
siently expressing LMP1 in the presence of serum, the activity
of each promoter was slightly decreased in the presence of
LMP1. These data indicate either that the LMP1 responsive
sequences are not contained within these constructs or that the
promoter is activated by LMP1 by mechanisms not sensitive to
the experimental conditions tested.
TABLE 1. Quantitative PCR primers
Gene name (accesssion no.) Sense primer Antisense primer
EGFR (X00588) TGCGTCTCTTGCCGGAAT GGCTCACCCTCCAGAAGC
H-ras (AF493916) TACGGCATCCCCTACATCGA ACCAACGTGTAGAAGGCATCCT
Rel A (M62399) CCTGGAGCAGGCTATCAGTCA CCCACGCTGCTCTTCTATAGGA
c-Src (NM_004383) CGTGTTTGCGCTTGACCAT AAATCCAAGCCCCTGACAGA
Actin (NM_001101) TCACCCACACTGTGCCCATCTACGA CAGCGGAACCGCTCATTGCCAATGG
Annexin A2 (NM_004039) GATGAGGTCACCATTGTCAACATT GGCGAAGGCAATATCCTGTCT
Cycin E1 (T54121) AGGGTCAAGTAGCACCTTCCATAG CCAGCCACCTCCCAGACA
DDX21 (U41387) CGGACAGGAACTGGGAAGAC TCTTGCAGTTCCCCATGAAGT
Id3 (NM_002167) AGGGATGGGCCCCAACT AGGTTTAGTCTCCAGGAAGGGATT
LZ16 (NM_013275) AGTTTCTCTAACCAAGACCCCAAA CTCGCTCCCTCACCTCCTT
Vimentin (NM_003380) ACACCCTGCAATCTTTCAGACA GATTCCACTTTGCGTTCAAGGT
Id1 (NM_002165) AGAACCGCAAGGTGAGCAA CCAACTGAAGGTCCCTGATGTAG
CSDA (NM_003651) TCCAAACCAGCCGTCTGTTC GGCGACGCCGGTAATTG
STIPI (NM_006819) ACCGCTGCCCTCGAGTTC AGAGCAGCCGAGACAGCAA
DNAJ A1 (NM_001539) GCACTGTGTGGCTTCCAGAA TGACCTGGATGAGAGGTGATGA
13472 EVERLY ET AL. J. VIROL.
Id proteins in C33A cells. To determine whether increased
RNA levels led to increased Id proteins levels, Western blot-
ting was performed. C33A cells stably expressing LMP1 or
LMP1 mutants 1–231 (CTAR2 deleted) or 187–351 (CTAR1
deleted) were examined for Id1 and Id3 protein levels relative
to vector control cells. As with the mRNA levels, both Id1 and
Id3 proteins were increased in the presence of LMP1 (Fig. 3).
Id1 was detected in vector control cells and dramatically in-
creased in the LMP1 expressing cells (Fig. 3, top). Id3 was not
detected in the absence of LMP1 but clearly induced when
LMP1 was expressed. The 1–231 mutant also induced the ex-
pression of both Id1 and Id3, but the 187–351 mutant only
induced Id3. These data indicate that LMP1 containing
CTAR1 is sufficient to induce expression of both Id1 and Id3,
while LMP1 lacking CTAR1 can increase Id3 but cannot in-
duce Id1. Densitometry quantification of the Id1 bands indi-
cated that LMP1 and 1–231 induce Id1 protein three- and
twofold, respectively. Id1 is similar to other genes that have
FIG. 1. Quantitative PCR analysis of gene expression in the presence of LMP1. RNA from LMP1 and control C33A cells was purified, and
quantitative reverse transcription-PCR was performed. The number of cycles required to reach a given fluorescence intensity threshold (Ct) was
determined, and different conditions were compared using Ct and Ct relative to actin control amplification. Differences were calculated as
2Ct. Each reaction and condition were performed in triplicate, and genes judged to be significantly altered (Ct  1) were repeated. Error bars
represent the standard deviation of three different experiments.
TABLE 2. Genes induced by LMP1 on microarrays
Gene Description Accession no. Scorea
ANXA2 Annexin A2 NM_004039 2.75
ID3 Inhibitor of DNA binding 3, dominant negative helix-loop-helix protein X69111 2.46
ID3 Inhibitor of DNA binding 3, dominant negative helix-loop-helix protein AA482119 2.40
GAGE1 G antigen 1 NM_001468 2.35
DNAJA1 DnaJ (Hsp40) homolog, subfamily A, member 1 NM_001539 2.32
CSDA Cold shock domain protein A NM_003651 2.32
WDR3 WD repeat domain 3 NM_006784 2.22
IL1RL1LG Putative T1/ST2 receptor binding protein NM_006858 2.18
NDRG1 N-myc downstream regulated gene 1 NM_006096 2.15
DDX21 DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 21 U41387 2.13
VIM Vimentin NM_003380 2.08
SLC6A7 Solute carrier family 6 (neurotransmitter transporter, L-proline), member 7 NM_014228 2.08
CNN3 Calponin 3; acidic NM_001839 2.06
CCNE1 Cyclin E1 T54121 2.05
ID4 Inhibitor of DNA binding 4, dominant negative helix-loop-helix protein AA453341 2.05
STIP1 Stress-induced-phosphoprotein 1 (Hsp70/Hsp90-organizing protein) NM_006819 2.03
BTF3 Basic transcription factor 3 NM_001207 2.01
CCT5 Chaperonin containing TCP1, subunit 5 (epsilon) AF275798 2.00
ID1 Inhibitor of DNA binding 1, dominant negative helix-loop-helix protein NM_002165 1.81
LZ16 Nasopharyngeal carcinoma susceptibility protein NM_013275 1.43
RELA v-rel reticuloendotheliosis viral oncogene homolog A, nuclear factor of
kappa light polypeptide gene enhancer in B-cells 3, p65 (avian)
M62399 1.3
HRAS v-Ha-ras Harvey rat sarcoma viral oncogene homolog NM_005343 1.27
CSK c-src tyrosine kinase NM_004383 1.21
a Score, average of the log2(mean red/green) and log2(median red/green) from three experiments. red, vector control; green, LMP1 signal.
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been identified that are uniquely activated through CTAR1,
including the EGFR and TRAF1.
Id1 expression in LMP1-transformed Rat-1 foci. Because
the Id proteins are known regulators of cell growth, it is pos-
sible that the Id proteins contribute to LMP1-mediated trans-
formation of rodent fibroblasts. To determine if the induction
of Id proteins by LMP1 occurs during rodent fibroblast trans-
formation, Rat-1 foci from cells transduced with control and
LMP1-expressing retroviruses were examined by phase-con-
trast and immunofluorescence microscopy. Foci were only ob-
served in LMP1 transduced cells (Fig. 4A and C and data not
shown). Immunofluorescence staining for LMP1 was restricted
to the foci (Fig. 4B). These data reveal that LMP1 expression
always induces focus formation. Furthermore, bright staining
for Id1 was restricted to the foci and coincident with LMP1
expression (Fig. 4D). Under low contrast, low levels of Id1
expression were detected in control transduced cells and cells
surrounding the LMP1 foci (data not shown). These data in-
dicate that Id1 is increased in Rat-1 foci transformed by LMP1.
Id proteins and cdki’s in Rat-1 cells. To determine levels of
Id proteins and potential effects on cell cycle control proteins,
Rat-1 cells stably transduced with control or LMP1-expressing
retroviruses were selected and analyzed by Western blotting.
As with the C33A cells, Rat-1 cells expressing LMP1 had
increased levels of Id1 and Id3 protein (Fig. 5A). Id1 has been
shown to negatively regulate cdki p16 expression by binding to
and sequestering Ets1 and Ets2, E-box proteins that regulate
p16 expression (26). Potential E-box binding sites are located
in the upstream regulatory regions of a number of cdki’s,
including p16, p15, p27, and p21 that are conserved between
rat, mouse, and humans (data not shown). In agreement with
previous studies (1, 29), the expression of cdki’s p16, p19, and
p21 was not detected in Rat-1 cells (data not shown). However,
p27, which is expressed in Rat-1 cells, was strikingly downregu-
lated in presence of LMP1 (Fig. 5B).
Cdk levels and activity in Rat-1 cells. cdki’s, like p27, bind to
and inhibit the activity of Cdk2 and Cdk4, thereby inhibiting
cell cycle progression. Studies with v-src transformation in
Rat-1 cells have shown that lower p27 levels result in increased
Cdk2 levels and activity. To determine if the decrease in p27
affected levels of Cdks, Cdk2 and Cdk4 were analyzed. Serum
starvation inhibits cell cycle progression; however, in the pres-
ence of LMP1, a large increase in Cdk2 levels was detected
(Fig. 5C). In the presence of serum, Cdk2 levels were un-
changed and Cdk4 was not detected in Rat-1 cells (data not
shown). An important target of the Cdks in the regulation of
the cell cycle is the Rb protein. To determine if LMP1 not only
regulates the levels, but also the activity of Cdks, phosphory-
lated Rb protein was examined with a phosphospecific Rb
antibody. Levels of Rb protein phosphorylated on T373 were
greatly increased in serum-starved LMP1-expressing cells but
FIG. 2. Id1 promoter reporter assays. C33A cells were transfected with control pRL-SV40, pGL3-Basic, or Id1 promoter reporter plasmids and
vector control or pM3-LMP1. Full-length reporter plasmid ID1-2.1 and truncated reporters ID1-985 and ID1-0.8 contain upstream promoter
regions from 2,100, 985, and 800 bp, respectively. ID1-mutA and ID1-mutB are derived from ID1-985, which contains the BMP-2
serum-responsive region, and each contains the triple-point mutations (TTT) that alter putative Egr-1 and Sp1 binding sites, respectively. Forty
hours posttransfection, cells were harvested, and dual-luciferase assays were performed. Relative luciferase activity was determined by the firefly
luciferase activity of the Id1 promoter constructs relative to control Renilla luciferase activity.
FIG. 3. Id1 and Id3 protein levels in C33A cells. C33A stable cell
lines were analyzed by Western blotting. A total of 50 g of total cell
lysates from the vector control, LMP1, 1–231, and 187–351 was ex-
amined for expression of Id1, Id3, and actin.
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not in cells transduced with control retroviruses (Fig. 5C).
Total Rb was increased approximately threefold in LMP1-
expressing Rat-1 cells under low-serum conditions (data not
shown). Levels of phosphorylated Rb protein under high-se-
rum conditions were high in both LMP1-expressing and con-
trol cells. Increased levels of Cdk2 and phosphorylation of Rb
indicates activation of Cdk2 complexes under low-serum con-
ditions. These data reveal that LMP1 expression abrogates the
normal cell cycle regulation imposed by serum deprivation.
Effects of LMP1 functional domain mutants on Id1, Id3,
p27, and Cdk2 in Rat-1 cells. LMP1 CTAR1 and CTAR2
mutants were also tested in Rat-1 cells for effects on the Id
proteins and cell cycle proteins. Rat-1 cells expressing LMP1
or 1–231 (CTAR2 deleted) increased Id1 and Id3 protein lev-
els compared to control cells, whereas levels were unchanged
in cells expressing LMP1 deleted for CTAR1 (187–351), de-
spite the high levels of 187-351 expression (Fig. 6). This is in
contrast to C33A cells where 187-351 increased Id3 levels.
Coordinate downregulation of p27 and increased Cdk2 were
also detected in LMP1 and 1-231-expressing cells, but p27 and
Cdk2 levels were unchanged in cells expressing the CTAR1
deletion mutant 187-351. These data indicate that in Rat-1
cells, LMP1 expression and signaling from CTAR1 are respon-
sible for the induction of the Id proteins, downregulation of
p27, and increased levels of Cdk2.
DISCUSSION
In this study, genomic analysis of cells expressing LMP1
revealed induction of two genes in the family of inhibitors of
differentiation, the Id1 and Id3 genes. Few other genes were
FIG. 4. Detection of LMP1 and increased Id1 expression in transformed foci of Rat-1 cells. Rat-1 cells were transduced with control and LMP1
retroviruses, and foci were allowed to form for 10 days. Cells were fixed, and immunofluorescence staining was performed. Phase-contrast (A and
C) and immunofluorescence (B and D) micrographs of LMP1 and Id1 are depicted. The same foci were examined in panels A and B and in panels
C and D.
FIG. 5. Id proteins and cell cycle control proteins in Rat-1 cells. Rat-1 cells transduced with Babe (control) or LMP1-expressing retroviruses
were examined by Western blotting. Levels of Id1 and Id3 were determined in the presence of LMP1 (A), and levels of HA-tagged LMP1 and p27
expression were determined (B). Cell cycle control proteins Cdk2 and phosphorylated Rb were detected in the presence of serum or following
serum starvation for 36 h (C). Actin was used as a control for equal loading, and 50 g of protein was loaded in each lane.
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induced by LMP1 as detected by microarrays. Id1 and Id3
protein levels were increased in C33A and Rat-1 cells, and
Rat-1 foci transformed with LMP1 had increased Id1 protein.
Id proteins are known to downregulate cdki’s. In this study,
p27 was decreased in LMP1-expressing Rat-1 cells, and Cdk2
levels and phosphorylation of Rb were increased. Importantly,
LMP1 regulation of Id1, Id3, p27, and Cdk2 mapped to the
CTAR1 signaling domain.
Microarray analyses are widely used to determine global
transcriptional changes in cell lines and tumor samples and
often reveal hundreds of genes regulated under different con-
ditions. In the present study, the limited number of genes
affected in the presence of LMP1 was surprising. LMP1 acti-
vates NF-B, c-Jun N-terminal kinase, MAPK, and PI3K path-
ways and would be expected to alter the expression of a num-
ber of genes and gene families. Studies from our laboratory
indicated that as stable cell lines are passaged, LMP1 expres-
sion declines. Although initial, low-passage, high-LMP1-ex-
pressing cells may dramatically regulate the expression of more
genes, lower levels of LMP1 are more likely to be physiologi-
cally relevant to the levels of LMP1 expressed in EBV-infected
cells.
The lack of sensitivity of microarrays may have limited the
number of genes identified in the present study. In C33A cells,
upregulation of EGFR in the presence of LMP1 was expected
(22). Three separate spots for EGFR on the microarray did not
score as significantly different in the presence of LMP1 despite
Western blots and RNase protection assays for EGFR that
indicated upregulation in these cells. The quantitative PCR
analysis reveals that EGFR expression is low in C33A cells,
taking about 25 cycles to reach the fluorescence detection
level, while it only took actin 12 cycles and most other genes
between 16 to 18 cycles (data not shown). Therefore, EGFR is
expressed between at levels 100-fold to several thousandfold
lower than other genes examined, and differences in gene ex-
pression levels may have been masked by the inherent noise in
the microarray technique. Other genes, like the EGFR gene
(whose expression is low), may be significantly regulated by
LMP1 but not scored by microarray because of a lack of sen-
sitivity. Alternatively, expression of genes important for growth
may be enhanced by passage in tissue culture and obscure the
effects of LMP1.
Two important genes induced by LMP1 are the Id1 and Id3
genes. These two genes are members of a family of genes
named for their function as inhibitors of differentiation and
inhibitors of DNA binding (31). The proteins expressed by
these genes (Id1, Id2, Id3, and Id4) all contain helix-loop-helix
domains that allow them to bind to helix-loop-helix transcrip-
tion factors, called E-box proteins. However, the Id proteins
lack DNA binding domains and act as dominant-negative tran-
scription factors. Id proteins are highly expressed in prolifer-
ating cells and some cancers and downregulated in differenti-
ating cells and during senescence. LMP1 has been reported to
inhibit epithelial cell differentiation, and this effect likely re-
flects the increased Id expression (5).
In a genomic analysis of LMP1-transduced nasopharyngeal
carcinoma (NPC) cells, the NP69 cell line revealed only 28
genes as being regulated more than twofold by LMP1 (20).
These data and our findings suggest that LMP1 may not reg-
ulate the expression of a large number of genes in epithelial
cells. Vimentin was upregulated in both C33A and NP69 cells
as determined by arrays. Vascular endothelial growth factor
induction by LMP1 that has been identified by other studies
(24) was also indicated by array in NP69 cells. The Id proteins
were not identified as being upregulated in NP69 cells, but
several markers for differentiation, cytokeratin 14 and cytoker-
atin 19 and differentiation control molecules Jagged2 and
Notch1m were downregulated. Although induction of Id pro-
teins was not detected in NP69 cells, downregulation of differ-
entiation markers would be consistent with the activity of Id
proteins.
A recent report indicated that LMP1 induces Id1 in epithe-
lial cells (19). Upregulation of Id1 was inhibited by NF-B
inhibitors and dominant-negative IB and was not inhibited
by MAPK or SAPK inhibitors, or dominant-negative MAPK or
SAPK mutants. This study identified two putative NF-B sites
at positions 1110 and 1947 within the Id1 promoter but did
not test their function. While these sites were contained within
the full-length reporter construct, ID-2.1, this construct was
unresponsive to LMP1 in C33A and Rat-1 cells in the presence
or absence of serum (Fig. 2). These sets of promoter reporter
constructs respond appropriately to serum, as has been previ-
ously described (11, 12).
FIG. 6. Regulation of Id proteins and cell cycle proteins by LMP1
mutants in Rat-1 cells. Rat-1 cells transduced with Babe (control),
LMP1, or LMP1 mutant 1–231 (CTAR2 deleted) or 187–351
(CTAR1 deleted) retroviruses were examined by Western blotting.
Expression of wild-type and mutant LMP1 proteins was detected with
the HA epitope tag (top). Id proteins (Id1 and Id3) and cell cycle
control proteins (Cdk2 and p27) were also detected (see the panels
below). Lysates used for Cdk2 were from cells that were serum starved
for 30 h. Actin was used as a loading control, and 25 g of total cell
lysates was loaded in each well.
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The roles of the different signaling domains of LMP1 in the
upregulation of Id proteins are presently unclear. In the
present study with Rat-1 cells, the CTAR2-deleted mutant,
1-231, induced Id1 and Id3 and downstream effector mole-
cules, but the CTAR1-deleted mutant 187-351 did not induce
either Id protein or alter cell cycle proteins. However, in C33A
cells, although 1-231 was able to upregulate Id1 and Id3, 187-
351 was only able to upregulate Id3. Finally, in work published
by others using 293 cells (19), either CTAR1 or CTAR2 was
able to induce Id1 expression, although Id3 and downstream
molecules were not examined. Differing activities of the CTAR
mutants in other cell lines likely reflects cell specific differences
between 293, C33A, and Rat-1 cells.
The data presented in the present study suggest that LMP1-
mediated Id induction and regulation of cell cycle proteins
during Rat-1 cell transformation occurs primarily through sig-
naling initiated by CTAR1. It will be important to determine
the role of Id protein expression in the transformation of Rat-1
cells by LMP1 and LMP1 CTAR mutants. Studies of B-lym-
phocyte transformation by LMP1 have revealed that CTAR1 is
required for transformation and that deletion of CTAR2 can
be complemented by growth on fibroblast feeder layers (2, 7,
14, 15).
cdki’s and the Rb pathway are important regulators of cell
cycle G1/S entry and replicative senescence. The cdki p16 is
often not expressed in NPC cells (21, 33). LMP1 stimulates the
CRM1-dependent nuclear export of Ets2, leading to a de-
crease in p16 expression (25). Id1 and several E-box proteins,
E47, Ets1, and Ets2, regulate the p16INK4 promoter; E-box
binding sites within the promoter of p16 are conserved be-
tween mouse, human, and rat cells (26, 36). Another E-box
protein, E2A, regulates cdki p21 in conjunction with Id1, con-
trolling cell growth (27). Although regulation of cdki’s by Id
proteins in Rat-1 cells is unknown, examination of the promot-
ers of several cdki’s, including p16, p15, p27, and p21, revealed
the presence of putative E-box binding sites contained within
the upstream regulatory regions of all of these promoters that
were conserved between rats, mice, and humans (data not
shown). This indicates that all of these promoters might be
regulated by Id proteins by a similar mechanism. Regulation of
cdki p27 in Rat-1 cells and cdki p16 in NPC cells by LMP1 via
induction of Id proteins may represent a common mechanism
of transformation by LMP1 by altering cdki levels.
It is likely that the effects of LMP1 on Id proteins (down-
regulation of p27, increased Cdk2, and phosphorylation of Rb)
are important for the transformation of rodent fibroblasts. The
importance of these effects is supported by transformation of
Rat-1 cells with v-src (10, 29). Transformation with v-src also
leads to the downregulation of p27, activation of Cdk2, and
phosphorylation of Rb. Interestingly, regulation of p27 by v-src
was dependent upon PI3K signaling and led to increased deg-
radation of p27. LMP1 also activates PI3K signaling (6) and
could negatively regulate p27 at the level of proteolytic degra-
dation induced by PI3K activation, as well as the transcrip-
tional repression via the binding of Id proteins to E-box pro-
teins. The activation of PI3K by LMP1 is a CTAR1-specific
activity. CTAR1 was responsible for effects on p27 in the Rat-1
cells, supporting the importance of this signaling domain.
The importance of p27 regulation in EBV-infected cells is
indicated by other studies. EBNA3C, which regulates LMP1
transcription during EBV latency (35), competes with p27 for
binding to cyclin A in lymphocytes. EBNA3C interacts with
cyclin A, stimulates cyclin A/Cdk2 kinase activity, and rescues
p27 inhibition of cyclin A/Cdk2 (17). Phosphorylation of Rb
was also stimulated in the presence of EBNA3C. In lympho-
cytes, activities of LMP1 and EBNA3C represent a two-
pronged attack upon the Cdks and reveal two distinct mecha-
nisms EBV has developed to deregulate the mammalian cell
cycle. However, since EBNA3C is not expressed in most EBV-
associated cancers, LMP1 may be responsible for effects on cell
cycle proteins in these malignancies.
Many cancers have dysregulation of the cell cycle through
mutations or deletions of the p53 or pRb genes, and DNA
tumor viruses also target cell cycle regulatory and checkpoint
molecules. Human papillomavirus (HPV) encodes two pro-
teins that target cell cycle proteins for degradation, E6 and E7.
HPV E6 induces the degradation of p53, and E7 binds and
promotes the degradation of pRB and pRb family members
p107 and p130. These activities of E6 and E7 lead to increased
E2F-mediated gene transcription, unscheduled cyclin/Cdk2 ac-
tivity, and cell cycle progression. Thus, in HPV-associated can-
cers, p53 and Rb are not mutated. EBV-associated cancers also
have wild-type p53 and Rb, indicating that EBV also likely
affects the regulation of the mammalian cell cycle.
The data presented in this study suggest that the EBV on-
cogene LMP1 affects the cell cycle by inducing the expression
of cell cycle regulatory proteins, thereby eliminating the neces-
sity for mutations. As opposed to inducing the degradation of
p53 and pRB, LMP1 induces the expression of Id proteins that
in turn regulate the expression of cell cycle proteins inducing
transformation. This study identifies a new mechanism through
which LMP1 and EBV affect cell growth.
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